Invention Publication
- Patent Title: EUKARYOTIC CELLS COMPRISING ADENOVIRUS-ASSOCIATED VIRUS POLYNUCLEOTIDES
-
Application No.: US18047341Application Date: 2022-10-18
-
Publication No.: US20230193312A1Publication Date: 2023-06-22
- Inventor: Michael Goren , Yu Zhao , Alexandros Strikoudis , Darya Burakov , Gang Chen
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C07K14/005 ; C12N15/67

Abstract:
The present inventions provide eukaryotic cells, such as mammalian cells, that comprise adeno-associated virus (AAV) polynucleotides, including AAV capsid proteins (Cap), and are capable of expressing the polypeptides encoded by the AAV polynucleotides, and thereby are capable of producing AAV, including recombinant AAV. The eukaryotic cells also may comprise adenovirus (Ad) polynucleotides. The present inventions also provide methods of expressing AAV polynucleotides, as well as Ad polynucleotides, in eukaryotic cells, such as CHO cells, HEK 293 and BHK cells. The present inventions further provides other products and methods described herein.
Public/Granted literature
- US12234472B2 Eukaryotic cells comprising adenovirus-associated virus polynucleotides Public/Granted day:2025-02-25
Information query
IPC分类: